PRESS RELEASE published on 10/04/2023 at 13:00, 2 years 8 months ago Moderna Announces Positive Phase 1/2 Data from mRNA-1083, the Company's Combination Vaccine Against Influenza and COVID-19
PRESS RELEASE published on 09/30/2023 at 01:37, 2 years 8 months ago Moderna Recommends Shareholders Reject Amended “Mini-Tender” Offer by TRC Capital Investment Corporation
PRESS RELEASE published on 09/14/2023 at 16:15, 2 years 9 months ago EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna’s Updated Covid-19 Vaccine in The European Union
PRESS RELEASE published on 09/13/2023 at 12:30, 2 years 9 months ago Moderna Expands the Field of mRNA Medicine with Positive Clinical Results Across Cancer, Rare Disease, and Infectious Disease
PRESS RELEASE published on 09/11/2023 at 19:53, 2 years 9 months ago Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccine
PRESS RELEASE published on 09/11/2023 at 13:00, 2 years 9 months ago Moderna and Immatics Announce Strategic Multi-Platform Collaboration to Develop Innovative Oncology Therapeutics
PRESS RELEASE published on 09/08/2023 at 22:37, 2 years 9 months ago Moderna Recommends Shareholders Reject “Mini-Tender” Offer by TRC Capital Investment Corporation
PRESS RELEASE published on 09/06/2023 at 22:30, 2 years 9 months ago Moderna to Participate at Morgan Stanley 21st Annual Global Healthcare Conference
PRESS RELEASE published on 09/06/2023 at 13:00, 2 years 9 months ago Moderna Clinical Trial Data Confirm Its Updated Covid-19 Vaccine Generates Strong Immune Response in Humans Against BA.2.86
PRESS RELEASE published on 08/30/2023 at 13:00, 2 years 9 months ago Moderna to Host Investor Event - R&D Day and Business Updates
Published on 06/20/2026 at 01:00, 1 day 3 hours ago Onco-Innovations Announces Non-Brokered LIFE Offering
Published on 06/20/2026 at 00:00, 1 day 4 hours ago Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development
Published on 06/19/2026 at 04:30, 2 days ago Uraniumx Discovery Corp. Announces Acquisition of Common Shares of Gold'n Futures Mineral Corp
Published on 06/19/2026 at 01:20, 2 days 3 hours ago American Hotel Income Properties REIT LP Reports Voting Results of Annual and Special Meeting
Published on 06/19/2026 at 01:07, 2 days 3 hours ago Usha Resources Announces Share Issuance in Payment of Debenture Interest, Adopts Semi-Annual Reporting
Published on 06/20/2026 at 21:25, 7 hours 17 minutes ago VIVATECH 2026 CELEBRATES ITS 10TH ANNIVERSARY WITH A RECORD EDITION SURPASSING 200,000 VISITORS
Published on 06/20/2026 at 06:00, 22 hours 42 minutes ago Successful debut of International Symposium on Emergency Response and Aeromedical Services in Hong Kong
Published on 06/19/2026 at 20:17, 1 day 8 hours ago 2CRSi SA: 2CRSi Responds Point-by-Point to the Grizzly Research Report and Reaffirms the Reality of Its Business Operations
Published on 06/19/2026 at 20:17, 1 day 8 hours ago 2CRSi SA: 2CRSi répond point par point au rapport de Grizzly Research et réaffirme la réalité de son activité
Published on 06/19/2026 at 19:01, 1 day 9 hours ago Fuller, Smith & Turner PLC: Publication of the Annual Report and Accounts for the 52 weeks ending 28 March 2026 and Notice of 2026 Annual General Meeting
Published on 06/19/2026 at 19:33, 1 day 9 hours ago Déclaration hebdomadaire d'opérations effectuées du 15 au 19 juin 2026
Published on 06/19/2026 at 19:33, 1 day 9 hours ago Disclosure of transactions in own shares from June 15 to June 19, 2026
Published on 06/19/2026 at 19:23, 1 day 9 hours ago Imerys-06-2026-communique-capital-droits-de-vote-au-31-mai-2026
Published on 06/19/2026 at 19:23, 1 day 9 hours ago Imerys-06-2026-information-share-capital-and-voting-rights-as-of-31-May-2026
